ID: ALA3827382

Max Phase: Preclinical

Molecular Formula: C8H5N5S

Molecular Weight: 203.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1csc(-c2ccnc3nnnn23)c1

Standard InChI:  InChI=1S/C8H5N5S/c1-2-7(14-5-1)6-3-4-9-8-10-11-12-13(6)8/h1-5H

Standard InChI Key:  ZHULYTZTHZIVDH-UHFFFAOYSA-N

Associated Targets(Human)

Pancreatic alpha-amylase 74 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Alpha-glucosidase MAL12 70 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 203.23Molecular Weight (Monoisotopic): 203.0266AlogP: 1.25#Rotatable Bonds: 1
Polar Surface Area: 55.97Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.20CX LogD: 1.20
Aromatic Rings: 3Heavy Atoms: 14QED Weighted: 0.60Np Likeness Score: -2.96

References

1. Suresh L, Onkara P, Kumar PS, Pydisetty Y, Chandramouli GV..  (2016)  Ionic liquid-promoted multicomponent synthesis of fused tetrazolo[1,5-a]pyrimidines as α-glucosidase inhibitors.,  26  (16): [PMID:27406797] [10.1016/j.bmcl.2016.06.086]

Source